Trevi Therapeutics Inc. (TRVI)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.77
-0.01 (-0.26%)
At close: Jan 17, 2025, 3:59 PM
3.76
-0.13%
After-hours Jan 17, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -29.07M | -29.15M | -33.94M | -32.76M | -26.05M | -20.55M | -12.86M | -11.09M |
Depreciation & Amortization | 123.00K | 43.00K | 50.00K | 47.00K | 39.00K | 23.00K | 4.00K | 4.00K |
Stock-Based Compensation | 2.25M | 2.33M | 2.54M | 2.42M | 1.13M | 496.00K | 205.00K | 142.00 |
Other Working Capital | -2.80M | -1.24M | 678.00K | 641.00K | 799.00K | -634.00K | 630.00K | -421.00K |
Other Non-Cash Items | -1.17M | -162.00K | 974.00K | 227.00K | 215.00K | 2.30M | 2.60M | 2.45M |
Deferred Income Tax | n/a | n/a | -82.00K | 9.00K | n/a | n/a | 1.35M | n/a |
Change in Working Capital | -3.85M | -1.23M | 1.51M | 1.06M | 1.58M | -568.00K | 722.00K | -1.49M |
Operating Cash Flow | -31.71M | -28.18M | -28.95M | -29.00M | -23.09M | -18.29M | -7.97M | -11.19M |
Capital Expenditures | -137.00K | -159.00K | n/a | -32.00K | -9.00K | -158.00K | -13.00K | n/a |
Acquisitions | n/a | -829.00K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -9.93M | -126.22M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 69.50M | 19.00M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 829.00K | n/a | -32.00K | -9.00K | n/a | n/a | n/a |
Investing Cash Flow | 59.43M | -107.37M | n/a | -32.00K | -9.00K | -158.00K | -13.00K | n/a |
Debt Repayment | -9.41M | -5.83M | n/a | 14.00M | n/a | -4.81M | -8.25M | 8.60M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -1.53M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | -2.24M | n/a | n/a | n/a |
Other Financial Acitivies | -211.00K | 11.73M | -408.00K | -415.00K | 10.35M | 9.98M | 29.97M | n/a |
Financial Cash Flow | -7.91M | 111.31M | 20.77M | 16.72M | 73.21K | 3.63K | 21.72M | 8.60M |
Net Cash Flow | 19.81M | -24.24M | -8.17M | -12.31M | 50.11M | -14.82M | 13.73M | -2.60M |
Free Cash Flow | -31.85M | -28.33M | -28.95M | -29.03M | -23.10M | -18.45M | -7.99M | -11.19M |